Cardiovascular Systems Inc Patents – Key Insights and Stats

Cardiovascular Systems Inc has a total of 1258 patents globally, out of which 622 have been granted. Of these 1258 patents, more than 37% patents are active. The United States of America is where Cardiovascular Systems Inc has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of Cardiovascular Systems Inc.

Cardiovascular Systems Inc was founded in 1989. Cardiovascular Systems, Inc. develops and produces medical devices. The Company offers a medical device that removes hardened plaque and calcium from arteries. As of September 2022, Cardiovascular Systems Inc has a market cap of $553.02 Million.

Do read about some of the most popular patents of Cardiovascular Systems Inc which have been covered by us in this article and also you can find Cardiovascular Systems Inc patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cardiovascular Systems Inc patent portfolio.

How many patents does the CEO of Cardiovascular Systems Inc have?

The CEO Scott R. Ward has 0 patents.

How many patents does Cardiovascular Systems Inc have?

Cardiovascular Systems Inc has a total of 1258 patents globally. These patents belong to 321 unique patent families. Out of 1258 patents, 468 patents are active.

How Many Patents did Cardiovascular Systems Inc File Every Year?

Cardiovascular Systems Inc Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCardiovascular Systems Applications FiledCardiovascular Systems Patents Granted
20115812
20121927
20133851
201412655
201511490
20165444
20176222
20185132
20197641
20203422
20211630
2022328

How many Cardiovascular Systems Inc patents are Alive/Dead?

Worldwide Patents

Cardiovascular Systems Inc Patents Portfolio

How Many Patents did Cardiovascular Systems Inc File in Different Countries?

Cardiovascular Systems Inc Worldwide Patents

Countries in which Cardiovascular Systems Inc Filed Patents

CountryPatents
United States Of America320
Japan166
Europe155
Australia89
China87
Germany79
Canada76
Hong Kong (S.A.R.)48
Spain24
United Kingdom17
India17
Austria11
Denmark7
Singapore4
Korea (South)4
Malaysia2
France2
Philippines1
Russia1
Mexico1
New Zealand1
Brazil1
Israel1

Where are Research Centers of Cardiovascular Systems Inc Patents Located?

Research Centers of Cardiovascular Systems Inc Patents

10 Best Cardiovascular Systems Inc Patents

US6726696B1 is the most popular patent in the Cardiovascular Systems Inc portfolio. It has received 491 citations so far from companies like Nmt Medical Inc, Vysera Biomedical Limited and W.L. Gore & Associates, Inc.

Below is the list of 10 most cited patents of Cardiovascular Systems Inc:

Publication NumberCitation Count
US6726696B1491
US6494890B1390
US7025776B1341
US6540761B2303
US6783328B2242
US20110077673A1240
US20030139689A1231
US6632196B1194
US7182771B1191
US6635017B1190

Which Companies are using Cardiovascular Systems Inc Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Cardiovascular Systems Inc patent portfolio are Cardio Flow Inc, Boston Scientific and Terumo.

List of the top forward citing Companies –

CompanyNumber of Patents
Cardio Flow Inc18
Boston Scientific15
Terumo10
Medtronic10
Covidien8
Olympus Corporation6
Philips5
Saphena Medical Inc4
Gearbox Llc4
Cook Medical Technologies Llc4

Count of 102 and 103 Type Rejections based on Cardiovascular Systems Inc Patents

Top Cardiovascular Systems Inc Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US7229431B212
US7025776B19
US6524249B29
US7588549B28
US6635017B18
US6726696B18
US7338441B27
US8177801B27
US8628550B27
US6783328B27
US7182771B17
US9050126B26
US6632196B16
US20100292532A16
US9289230B25

What Percentage of Cardiovascular Systems Inc US Patent Applications were Granted?

Cardiovascular Systems Inc (Excluding its subsidiaries) has filed 123 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 90 have been granted leading to a grant rate of 75.0%.

Below are the key stats of Cardiovascular Systems Inc patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Cardiovascular Systems Inc?

Law FirmTotal ApplicationsSuccess Rate
Barnes & Thornburg Llp8772.62%
Winthrop & Weinstine Pa10100.00%
Fish & Richardson Pc875.00%
Adsero Ip Llc7100.00%
Hamre Schumann Mueller & Larson Pc520.00%
Fulwider Patton Llp2100.00%
Darren J Milliken1100.00%
Gregory P Kaihoi1100.00%
Lerner Greenberg Stemer Llp10.00%
Perman & Green Llp1100.00%

What are Cardiovascular Systems Inc key innovation segments?

What Technologies are Covered by Cardiovascular Systems Inc?

The chart below distributes patents filed by Cardiovascular Systems Inc in different countries on the basis of the technology protected in patents. It also represents the markets where Cardiovascular Systems Inc thinks it’s important to protect particular technology inventions.

R&D Focus: How has Cardiovascular Systems Inc search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Cardiovascular Systems Inc?

Related Articles

1s1 Energy Patents – Insights & Stats (Updated 2024)

1s1 Energy has a total of 36 patents globally, out of which 6 have been granted. Of these 36 patents, more than 86% patents are active. United States of America is where 1s1 Energy has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, United States

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.